Literature DB >> 1502198

Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.

S Kitayama1, S Shimada, H Xu, L Markham, D M Donovan, G R Uhl.   

Abstract

Polar amino acids lying within three hydrophobic regions of the dopamine transporter (DAT) are analogous to those important for ligand recognition by catecholamine receptors. Possible functional significance of these amino acids was examined by expressing DAT cDNAs mutated in these polar residues. Replacement of aspartate at position 79 with alanine, glycine, or glutamate dramatically reduced uptake of [3H]dopamine and the tritium-labeled Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium (MPP+) and reduced the mutants' affinity for the tritium-labeled cocaine analog (-)-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane (CFT) without affecting Bmax. Replacement of the serine residues at positions 356 and 359 in the seventh hydrophobic region by alanine or glycine caused reductions in [3H]dopamine and [3H]MPP+ uptake, whereas [3H]CFT binding was less affected. Substitution of two serines in the eighth hydrophobic region yielded wild-type values for [3H]dopamine and [3H]MPP+ uptake and [3H]CFT binding. These results demonstrate that aspartate and serine residues lying within the first and seventh hydrophobic putative transmembrane regions are crucial for DAT function and provide identification of residues differentially important for cocaine binding and for dopamine uptake.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1502198      PMCID: PMC49795          DOI: 10.1073/pnas.89.16.7782

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  Sodium-dependent neurotransmitter reuptake systems.

Authors:  S G Amara; T Pacholczyk
Journal:  Curr Opin Neurobiol       Date:  1991-06       Impact factor: 6.627

2.  Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.

Authors:  K A Neve; B A Cox; R A Henningsen; A Spanoyannis; R L Neve
Journal:  Mol Pharmacol       Date:  1991-06       Impact factor: 4.436

3.  Cloning and expression of a cocaine-sensitive rat dopamine transporter.

Authors:  J E Kilty; D Lorang; S G Amara
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

4.  Cloning of a serotonin transporter affected by antidepressants.

Authors:  B J Hoffman; E Mezey; M J Brownstein
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

5.  Ligand autoradiographic receptor screening. II. Expression of receptor cDNA in transfected COS cells grown on polyester disks and its recovery.

Authors:  J C Schaeffer; C L Lin; S Kitayama; G R Uhl
Journal:  Brain Res Mol Brain Res       Date:  1991-02

6.  Intrahelical hydrogen bonding of serine, threonine and cysteine residues within alpha-helices and its relevance to membrane-bound proteins.

Authors:  T M Gray; B W Matthews
Journal:  J Mol Biol       Date:  1984-05-05       Impact factor: 5.469

7.  Cloning of a Na(+)- and Cl(-)-dependent betaine transporter that is regulated by hypertonicity.

Authors:  A Yamauchi; S Uchida; H M Kwon; A S Preston; R B Robey; A Garcia-Perez; M B Burg; J S Handler
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

8.  Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.

Authors:  S Shimada; S Kitayama; C L Lin; A Patel; E Nanthakumar; P Gregor; M Kuhar; G Uhl
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

9.  Cloning and expression of a functional serotonin transporter from rat brain.

Authors:  R D Blakely; H E Berson; R T Fremeau; M G Caron; M M Peek; H K Prince; C C Bradley
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

10.  Cloning and expression of a rat brain GABA transporter.

Authors:  J Guastella; N Nelson; H Nelson; L Czyzyk; S Keynan; M C Miedel; N Davidson; H A Lester; B I Kanner
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

View more
  71 in total

Review 1.  Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6.

Authors:  Nian-Hang Chen; Maarten E A Reith; Michael W Quick
Journal:  Pflugers Arch       Date:  2003-04-29       Impact factor: 3.657

2.  The glial and the neuronal glycine transporters differ in their reactivity to sulfhydryl reagents.

Authors:  M J Roux; R Martinez-Maza; A Le Goff; B Lopez-Corcuera; C Aragon; S Supplisson
Journal:  J Biol Chem       Date:  2001-03-14       Impact factor: 5.157

3.  Inhibition of cocaine binding to the human dopamine transporter by a single chain anti-idiotypic antibody: its cloning, expression, and functional properties.

Authors:  Mitchell Ho; Mariangela Segre
Journal:  Biochim Biophys Acta       Date:  2003-07-30

Review 4.  Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?

Authors:  Horrick Sharma; Soumava Santra; Aloke Dutta
Journal:  Future Med Chem       Date:  2015-11-30       Impact factor: 3.808

Review 5.  Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters.

Authors:  Christopher K Surratt; Okechukwu T Ukairo; Suneetha Ramanujapuram
Journal:  AAPS J       Date:  2005-10-27       Impact factor: 4.009

6.  Structure and localisation of drug binding sites on neurotransmitter transporters.

Authors:  Aina W Ravna; Ingebrigt Sylte; Svein G Dahl
Journal:  J Mol Model       Date:  2009-02-24       Impact factor: 1.810

7.  Synthesis of 8-thiabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters.

Authors:  Duy-Phong Pham-Huu; Jeffrey R Deschamps; Shanghao Liu; Bertha K Madras; Peter C Meltzer
Journal:  Bioorg Med Chem       Date:  2006-10-27       Impact factor: 3.641

8.  Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains.

Authors:  C M Dersch; H C Akunne; J S Partilla; G U Char; B R de Costa; K C Rice; F I Carroll; R B Rothman
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

9.  Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium.

Authors:  K J Buck; S G Amara
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  The binding sites for cocaine and dopamine in the dopamine transporter overlap.

Authors:  Thijs Beuming; Julie Kniazeff; Marianne L Bergmann; Lei Shi; Luis Gracia; Klaudia Raniszewska; Amy Hauck Newman; Jonathan A Javitch; Harel Weinstein; Ulrik Gether; Claus J Loland
Journal:  Nat Neurosci       Date:  2008-06-22       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.